This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Infliximab enhances QOL in Crohn's disease. Pharmacoecon. Outcomes News 378, 10 (2002). https://doi.org/10.1007/BF03279552
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279552